Company news
China SXT Pharmaceuticals, Inc. news in 2026
China SXT Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
October 22, 2026
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
October 21, 2026
Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
October 9, 2026
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering
October 8, 2026
Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
July 24, 2026
China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering
July 23, 2026
China SXT Pharmaceuticals, Inc. Announces Share Re-classification
March 22, 2026
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
January 30, 2026
China SXT Pharmaceuticals, Inc. announces strategic initiative to apply AI technology across the TCM supply chain
January 15, 2026
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
January 9, 2026
China SXT Pharmaceuticals, Inc. announces strategic AI insights initiative to optimize Traditional Chinese Medicine portfolio, enhance market analysis and explore AI-supported clinic deployment
January 8, 2026